<?xml version="1.0" encoding="UTF-8"?>
<p id="p0075">There is an increased demand for the use of plant extracts and their compounds and this raises concerns about the safety, toxicity and quality of these products. Studies have reported the contamination of plant materials with medicinal properties by mycotoxins (
 <xref rid="bib19" ref-type="bibr">Ashiq et al., 2014</xref>; 
 <xref rid="bib174" ref-type="bibr">Mulaudzi, 2019</xref>; 
 <xref rid="bib12" ref-type="bibr">Altyn and Twaruzek, 2020</xref>; 
 <xref rid="bib150" ref-type="bibr">Thipe et al., 2020</xref>). Furthermore, research has shown that many plant extracts used in traditional medicine and as food ingredients are toxic and mutagenic. As such, a thorough screening of their toxicological properties is necessary. Those that show no signs of toxicity are given high priority (
 <xref rid="bib157" ref-type="bibr">Verschaeve and Van Staden, 2008</xref>; 
 <xref rid="bib132" ref-type="bibr">Sajid et al., 2019</xref>). The use of plant extracts, especially in exploiting their bioactive compounds, are exploited in the discovery and development of new antifungal and nutraceutical agents.
</p>
